Genmab A/S
Patents, Design & Utilities

Last updated:

List of all Genmab A/S patents 89 in total

Status Patent
Application
Utility: AXL ANTIBODY-DRUG CONJUGATES FOR USE IN TREATING CANCER External link
Filling date: 5 Sep 2025 Issue date: 1 Sep 2022
Application
Utility: DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES External link
Filling date: 5 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: ANTIBODIES AGAINST HUMAN CD38 External link
Filling date: 5 Sep 2025 Issue date: 30 Jun 2022
Grant
Utility: Humanized or chimeric CD3 antibodies External link
Filling date: 5 Sep 2025 Issue date: 14 Jun 2022
Application
Utility: POTENCY ASSAYS FOR ANTIBODY DRUG SUBSTANCE BINDING TO AN FC RECEPTOR External link
Filling date: 5 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: MONOCLONAL ANTIBODIES AGAINST HER2 External link
Filling date: 5 Sep 2025 Issue date: 2 Jun 2022
Application
Utility: BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING FOLLICULAR LYMPHOMA External link
Filling date: 5 Sep 2025 Issue date: 12 May 2022
Application
Utility: METHOD FOR TREATING CANCER External link
Filling date: 5 Sep 2025 Issue date: 5 May 2022
Application
Utility: BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA External link
Filling date: 5 Sep 2025 Issue date: 21 Apr 2022
Application
Utility: BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA External link
Filling date: 5 Sep 2025 Issue date: 14 Apr 2022
Application
Utility: BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING FOLLICULAR LYMPHOMA External link
Filling date: 5 Sep 2025 Issue date: 14 Apr 2022
Grant
Utility: Antibodies External link
Filling date: 5 Sep 2025 Issue date: 1 Mar 2022
Application
Utility: ANTIBODIES External link
Filling date: 5 Sep 2025 Issue date: 17 Feb 2022
Application
Utility: ANTIBODIES External link
Filling date: 5 Sep 2025 Issue date: 17 Feb 2022
Grant
Utility: Antibodies against human CD38 External link
Filling date: 5 Sep 2025 Issue date: 25 Jan 2022
Application
Utility: METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-VEGF ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE External link
Filling date: 5 Sep 2025 Issue date: 30 Dec 2021
Application
Utility: HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR External link
Filling date: 5 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: AXL-SPECIFIC ANTIBODIES FOR TREATMENT OF NON-SMALL CELL LUNG CANCER External link
Filling date: 5 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 External link
Filling date: 5 Sep 2025 Issue date: 2 Dec 2021
Application
Utility: BISPECIFIC ANTIBODIES AGAINST HER2 External link
Filling date: 5 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER External link
Filling date: 5 Sep 2025 Issue date: 7 Oct 2021
Grant
Utility: Antibodies External link
Filling date: 5 Sep 2025 Issue date: 28 Sep 2021
Application
Utility: ANTIBODIES External link
Filling date: 5 Sep 2025 Issue date: 23 Sep 2021
Application
Utility: BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF External link
Filling date: 5 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: METHOD FOR PRODUCING A CONTROLLED MIXTURE OF TWO OR MORE DIFFERENT ANTIBODIES External link
Filling date: 5 Sep 2025 Issue date: 2 Sep 2021
Application
Utility: AGONISTIC TNF RECEPTOR BINDING AGENTS External link
Filling date: 5 Sep 2025 Issue date: 19 Aug 2021
Grant
Utility: Monoclonal antibodies against HER2 External link
Filling date: 5 Sep 2025 Issue date: 17 Aug 2021
Grant
Utility: Methods of producing multispecific antibodies against CD40 and CD137 External link
Filling date: 5 Sep 2025 Issue date: 17 Aug 2021
Grant
Utility: Multispecific antibodies against CD40 and CD137 External link
Filling date: 5 Sep 2025 Issue date: 10 Aug 2021
Application
Utility: ANTIBODIES External link
Filling date: 5 Sep 2025 Issue date: 29 Jul 2021
Grant
Utility: Monoclonal antibodies against HER2 External link
Filling date: 5 Sep 2025 Issue date: 29 Jun 2021
Application
Utility: ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER External link
Filling date: 5 Sep 2025 Issue date: 17 Jun 2021
Application
Utility: HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF External link
Filling date: 5 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF External link
Filling date: 5 Sep 2025 Issue date: 3 Jun 2021
Application
Utility: ANTIBODY VARIANTS HAVING MODIFICATIONS IN THE CONSTANT REGION External link
Filling date: 5 Sep 2025 Issue date: 27 May 2021
Grant
Utility: Antibodies External link
Filling date: 5 Sep 2025 Issue date: 18 May 2021
Application
Utility: MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE External link
Filling date: 5 Sep 2025 Issue date: 29 Apr 2021
Application
Utility: HUMAN MONOCLONAL ANTIBODIES AGAINST CD25 External link
Filling date: 5 Sep 2025 Issue date: 15 Apr 2021
Application
Utility: METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE External link
Filling date: 5 Sep 2025 Issue date: 15 Apr 2021
Grant
Utility: Binding agents binding to PD-L1 and CD137 and use thereof External link
Filling date: 5 Sep 2025 Issue date: 6 Apr 2021
Application
Utility: ANTIBODIES External link
Filling date: 5 Sep 2025 Issue date: 11 Mar 2021
Application
Utility: AXL-SPECIFIC ANTIBODIES FOR CANCER TREATMENT External link
Filling date: 5 Sep 2025 Issue date: 11 Mar 2021
Application
Utility: STABLE IgG4 ANTIBODIES External link
Filling date: 5 Sep 2025 Issue date: 4 Mar 2021
Grant
Utility: Agonistic tumor necrosis factor (TNF) receptor binding agents External link
Filling date: 5 Sep 2025 Issue date: 23 Feb 2021
Application
Utility: ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER External link
Filling date: 5 Sep 2025 Issue date: 4 Feb 2021
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING BISPECIFIC ANTIBODIES DIRECTED AGAINST CD3 AND CD20 AND THEIR USES External link
Filling date: 5 Sep 2025 Issue date: 4 Feb 2021
Grant
Utility: Bispecific antibodies and methods for production thereof External link
Filling date: 5 Sep 2025 Issue date: 2 Feb 2021
Application
Utility: METHODS OF TREATING CANCER WITH A COMBINATION OF A PLATINUM-BASED AGENT AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE External link
Filling date: 5 Sep 2025 Issue date: 21 Jan 2021
Application
Utility: AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT External link
Filling date: 5 Sep 2025 Issue date: 24 Dec 2020
Grant
Utility: Rodent bispecific heterodimeric proteins External link
Filling date: 5 Sep 2025 Issue date: 15 Dec 2020

Showing 1 to 50 of 89 patents.